- Home
- SURG vs LSTA Comparison
SURG vs LSTA Comparison
Compare SURG & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- LSTA
- Stock Information
- Founded
- SURG 2006
- LSTA 1980
- Country
- SURG United States
- LSTA United States
- Employees
- SURG N/A
- LSTA N/A
- Industry
- SURG Advertising
- LSTA Misc Health and Biotechnology Services
- Sector
- SURG Consumer Discretionary
- LSTA Health Care
- Exchange
- SURG Nasdaq
- LSTA Nasdaq
- Market Cap
- SURG 56.5M
- LSTA 22.5M
- IPO Year
- SURG N/A
- LSTA N/A
- Fundamental
- Price
- SURG $3.18
- LSTA $2.72
- Analyst Decision
- SURG Strong Buy
- LSTA Strong Buy
- Analyst Count
- SURG 1
- LSTA 1
- Target Price
- SURG $9.00
- LSTA $15.00
- AVG Volume (30 Days)
- SURG 90.4K
- LSTA 23.5K
- Earning Date
- SURG 08-12-2025
- LSTA 08-11-2025
- Dividend Yield
- SURG N/A
- LSTA N/A
- EPS Growth
- SURG N/A
- LSTA N/A
- EPS
- SURG N/A
- LSTA N/A
- Revenue
- SURG $40,029,467.00
- LSTA $1,000,000.00
- Revenue This Year
- SURG $57.76
- LSTA N/A
- Revenue Next Year
- SURG $112.61
- LSTA N/A
- P/E Ratio
- SURG N/A
- LSTA N/A
- Revenue Growth
- SURG N/A
- LSTA N/A
- 52 Week Low
- SURG $1.05
- LSTA $1.87
- 52 Week High
- SURG $3.47
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- SURG 62.14
- LSTA 52.43
- Support Level
- SURG $3.28
- LSTA $2.34
- Resistance Level
- SURG $3.34
- LSTA $3.09
- Average True Range (ATR)
- SURG 0.24
- LSTA 0.25
- MACD
- SURG 0.04
- LSTA 0.01
- Stochastic Oscillator
- SURG 90.12
- LSTA 50.67
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.